Mergers & Acquisitions ·
Aurora Cannabis Inc. filed a Directors' Circular unanimously recommending shareholders reject a hostile takeover bid…
ACBAurora Cannabis Inc
Aurora Cannabis Inc. filed a Directors' Circular unanimously recommending shareholders reject a hostile takeover bid from Curaleaf Holdings, urging them to take no action and not tender their shares. The Board argues the offer undervalues Aurora, which is debt-free with approximately $149 million in cash, while exposing shareholders to Curaleaf's over $1 billion in debt and governance risks. Aurora's leadership asserts that accepting the bid would weaken shareholder voting rights, reducing ownership influence to approximately 3.2% of votes despite holding roughly 7.7% of equity in a combined entity. Independent analysts support the view that the bid fails to reflect Aurora's fundamental value or growth potential. Aurora Cannabis Inc. operates as a global leader in medical cannabis, manufacturing and distributing products across Canada, Europe, Australia, and New Zealand.